Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2374-2015Class I

SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and...

Ethicon Endo-Surgery Inc / initiated 2015-05-13 / Terminated / root cause: design

Ethicon Endo-Surgery Inc began a recall of SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide... on . FDA classified it as Class I and gives the reason as "Ethicon has found that disinfecting methods not specified in the Instructions For Use (IFU) have led to the degradation of the plastic material of the SEDASYS System Control Unit". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2374-2015
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ethicon Endo-Surgery Inc
Product
SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. Intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures.
Product code
PDR Computer-Assisted Personalized Sedation System
Reason for recall
Ethicon has found that disinfecting methods not specified in the Instructions For Use (IFU) have led to the degradation of the plastic material of the SEDASYS System Control Unit.
Root cause tag
design
FDA root cause
Device Design
Action
Sedasys, a Division of Ethicon Endo-Surgery, Inc. sent an Urgent Customer Notification letter dated May 27, 2015, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to do the following: 1. Please distribute this information to all staff within your facility who use the SEDASYS System 2. Complete the Business Reply Form (BRF) (Attachment A) confirming receipt of this notice within three (3) business days. The BRF may be given to your sales or service representative or sent to Sedasys by email at [email protected]. 3. Keep this notice visibly posted in your facility for awareness. 4. If you have any questions or concerns regarding the condition of your SEDASYS System including the Control Units, please contact your Sales or Service Representative. If you need clinical or product support, please contact your local sales representative or call our Customer Support Center at 1-800-SEDASYS (1-800-733-2797). If you need additional communications packages, contact 1-800-SEDASYS and reference Event 052715SED01. For questions regarding this recall call 513-337-7439.
Quantity in commerce
14 units
Distribution
Nationwide Distribution including OH, RI, TX & WA.
Product codes and lots
Model #SEDPRU01

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2374-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2374-2015Class ITerminatedVoluntary: Firm initiated